Success Metrics

Clinical Success Rate
97.1%

Based on 33 completed trials

Completion Rate
97%(33/34)
Active Trials
3(7%)
Results Posted
39%(13 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
12
26%
Ph phase_3
12
26%
Ph not_applicable
7
15%
Ph phase_4
10
22%
Ph phase_1
5
11%

Phase Distribution

5

Early Stage

12

Mid Stage

22

Late Stage

Phase Distribution46 total trials
Phase 1Safety & dosage
5(10.9%)
Phase 2Efficacy & side effects
12(26.1%)
Phase 3Large-scale testing
12(26.1%)
Phase 4Post-market surveillance
10(21.7%)
N/ANon-phased studies
7(15.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

33 of 36 finished

Non-Completion Rate

8.3%

3 ended early

Currently Active

3

trials recruiting

Total Trials

46

all time

Status Distribution
Active(4)
Completed(33)
Terminated(3)
Other(6)

Detailed Status

Completed33
unknown6
Active, not recruiting2
Withdrawn2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
46
Active
3
Success Rate
97.1%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (10.9%)
Phase 212 (26.1%)
Phase 312 (26.1%)
Phase 410 (21.7%)
N/A7 (15.2%)

Trials by Status

completed3372%
not_yet_recruiting12%
active_not_recruiting24%
terminated12%
recruiting12%
unknown613%
withdrawn24%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT02858310Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Completed
NCT07401745Phase 4

Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular Disorders

Active Not Recruiting
NCT07360431Phase 4

Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic Cholecystectomy

Not Yet Recruiting
NCT03817970Phase 3

Cisplatin Disposition and Kidney Injury

Active Not Recruiting
NCT06762860Not Applicable

Intravenous Granisetron Vs Dexmedetomidine on Postspinal in the Cesarean Section.

Unknown
NCT00868764Phase 1

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron

Completed
NCT00890565Phase 1

Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

Completed
NCT00873197Phase 1

PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV Granisetron

Completed
NCT00273468Phase 3

To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)

Completed
NCT06437236Not Applicable

Comparative Study Between Intravenous Granisetron and Ondansetron on Their Effect on Hemodynamics and Shivering After Spinal Anesthesia in Elective Cesarean Delivery

Recruiting
NCT05632224Phase 4

Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery

Unknown
NCT04501211Phase 2

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

Withdrawn
NCT05087615Phase 3

Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery

Completed
NCT03483870Phase 2

Effect of Granisetron on Morphine Induced Pruritus in Cesarean Section

Completed
NCT04918862Phase 3

A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA

Completed
NCT01536392Phase 3

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Completed
NCT04899817Phase 4

Granisteron Versus Metoclopramide in Laparoscopic Cholecystectomy

Unknown
NCT02230371Phase 4

Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles

Completed
NCT04613726Phase 3

The Effect of Intravenous Granisetron and Ondansetron in Patients Undergoing Cesarean Section

Completed
NCT03503292Phase 4

Pharmacogenomics and Post-Operative Nausea and Vomiting

Completed

Drug Details

Intervention Type
DRUG
Total Trials
46